https://www.avient.com/sites/default/files/2023-05/AVNT Q1 2023 Earnings Presentation.pdf
FX -11% FX -3% Total Avient -14% YoY Comparison against 2022 pro forma results • Aging infrastructure driving need for greater technological advancements and upgrades • Increased focus on strength and capacity of electrical grid plays into further adoption of composites into the market Where Avient Wins: UV, weather-resistance, customized capabilities Best-in-class customer responsiveness Local high-quality manufacturing, unparalleled breadth of portfolio Expanding position in insulators, utility poles, crossarms, and wind energy Avient Confidential 11 ENERGY 11 • Fiber-optic investments from AT&T, Corning, Commscope continue to drive industry toward innovation • $42B BEAD program in Infrastructure Bill to increase cable deployments; well-positioned to capitalize on “Made in America” requirement and “last mile” buildout Where Avient Wins: Flame retardance, weather-resistance enables faster, safer, more reliable connections Local manufacturing, unparalleled breadth of portfolio Expanding position in insulation for wire jacketing, 5G buildout TELECOMMUNICATIONS Source: U.S.
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 32 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi en t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 33 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi en t (2 01 1) A vi en t (2 01 8) A vi en t (2 02 3) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/news/specialty-and-sustainable-healthcare-material-solutions-avient-medtec-china-2023
Mevopur™ Medical-Grade Colorants and Functional Polymer Solutions meet or exceed requirements for regulations such as USP Class VI, ISO10993, EP3.1, and USP661.1.
They can be customized to meet specific regulatory demands such as USP Class VI, FDA CFR, and ISO 10993.
Versaflex™ HC 2110-57B TPEs comply with ISO 10993-4, ISO 10993-5, and USP Class VI and are suitable for Ethylene Oxide (EtO) sterilization without residue or allergens.